Akèy › Maladi Fabry
Etid klinik pou Maladi Fabry ap rekrite nan Etazini
10 etid pou Maladi Fabry ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Arlington, VA6 etid
- Atlanta, GA6 etid
- Minneapolis, MN4 etid
- Birmingham, AL4 etid
- Cincinnati, OH4 etid
- Pittsburgh, PA4 etid
- Salt Lake City, UT3 etid
- Cedar Rapids, IA3 etid
- Chicago, IL3 etid
- New York City, NY3 etid
Pa eta
- Alabama4 etid
- Georgia6 etid
- Illinois3 etid
- Iowa3 etid
- Minnesota4 etid
- New York4 etid
- Ohio4 etid
- Pennsylvania5 etid
- Utah3 etid
- Virginia6 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
Ap rekriteFaz 1/2
Laj 18 a 65 · Gason · Mizajou Sep 24, 2026 · NCT06270316A Study of Patients With Fabry Disease (US Specific)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06906367A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
Ap rekriteFaz 3
Laj 2 a 11 · Tout sèks · Mizajou Sep 1, 2026 · NCT06904261Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study
Ap rekriteEtid obsèvasyon
Laj 1 a 75 · Tout sèks · Mizajou Aug 14, 2026 · NCT01581424A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
Ap rekriteFaz 2/3
Laj 2 a 17 · Tout sèks · Mizajou Aug 10, 2026 · NCT06328608Cardiovascular Multimodality Imaging Study
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06610019Fabry Disease Registry & Pregnancy Sub-registry
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jun 23, 2026 · NCT00196742Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Mar 19, 2026 · NCT06941025A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Nov 14, 2025 · NCT06663358A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Jul 8, 2025 · NCT04252066Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.